Ki67 Recombinant Antibody

Applications

  • WB
  • FCM
  • IHC-P
  • IHC-F
  • IF(IHC-P)
  • IF(ICC)

Reactivity

  • Human
  • Mouse
  • Rat
Overview
Catalog # bsm-52455r
Product Name Ki67 Recombinant Antibody
Applications
WB FCM IHC-P IHC-F IF(IHC-P) IF(ICC)
Reactivity Human, Mouse, Rat
Specifications
Conjugation Unconjugated
Host Rabbit
Source KLH conjugated synthetic peptide derived from human Ki67
Clonality Recombinant
Clone # D9H1
Isotype IgG
Concentration 1mg/ml
Purification purified by Protein A.
Storage Buffer 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID 4288
Swiss Prot P46013
Subcellular location Nucleus
Synonyms KIA; MIB-; MIB-1; PPP1R105; KI67_HUMAN; MKI67; Antigen identified by monoclonal antibody Ki-67 (Antigen KI-67 | Antigen Ki67); marker of proliferation Ki-67; antigen identified by monoclonal antibody Ki-67; protein phosphatase 1, regulatory subunit 105; Molecular Immunology Borstel antibody 1
Background Ki67 antigen is the prototypic cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2 and M phase). It is absent in resting (G0) cells. Ki67 antibodies are useful in establishing the cell growing fraction in neoplasms (immunohistochemically quantified by determining the number of Ki67 positive cells among the total number of resting cells = Ki67 index). In neoplastic tissues the prognostic value is comparable to the tritiated thymidine labelling index. The correlation between low Ki67 index and histologically low grade tumours is strong. Ki67 is routinely used as a neuronal marker of cell cycling and proliferation.
Application Dilution
WB 1:1000-5000
FCM FCM1:50-100
IHC-P IHC-P1:200-1000
IHC-F IHC-F1:200-1000
IF(IHC-P) IFIHC-P1:200-1000
IF(ICC) IFICC1:200-1000